Global Anti-Snoring Devices Market Size is estimated to be about USD 0.91 billion in 2024 and estimated to reach about USD 1.45 billion by the year 2029, at a growth rate of CAGR of 9.8% during the forecasted period. The growth in this market is expected to be driven by the increasing incidence of sleep disorders such as sleep apnea; the rising technological advancements in sleep therapy devices; and the growing geriatric population with a subsequent rise in chronic diseases expected to drive the market growth. However, the high cost of oral sleep appliances and complex referral pathways are expected to restrain the growth of this market to a certain extent.
The major market players involved in this market are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (Canada), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), The Aurum Group (Canada), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed, Inc. (US), ZQuiet (US), Dream Systems Dental Sleep Lab (US), The Snore Reliever Company, LLC (US), The Pure Sleep Company (US), Tomed GmbH (Germany), THE AURUM GROUPS (Canada), Innovative Health Technologies (New Zealand), and Theravent, Inc. (US) among others.
To know about the assumptions considered for the study download the pdf brochure
F. HOFFMANN-LA ROCHE LTD.
In 2023, ResMed (US) generated approximately USD 4.1 billion in revenue from its Sleep and Respiratory Care business segment, which includes anti-snoring devices. In contrast, Vivo Therapeutics, Inc. (US) experienced a decline in revenue due to several challenges. These challenges included escalating inflation, increasing raw material costs and necessitating price adjustments, potentially reducing consumer demand. Additionally, global supply chain disruptions and geopolitical tensions have heightened economic uncertainty. Furthermore, higher interest rates have added to financial strain, impacting demand and capital acquisition.
SomnoMed (Australia)
The company had the second-largest market share, accounting for 4.3% in 2023. SomnoMed has a strong presence in North America and Europe and aims to expand further into emerging markets like the Asia Pacific. The company boasts a robust product portfolio, with FDA- and CE Mark-approved products that have helped it maintain its market presence. SomnoMed has been leading in technological advancements and frequently introduces new products such as SomnoDent Herbst, SomnoDent Fusion, SomnoDent Herbst Advance, and SomnoDent with Compliance Recorder. Additionally, the company has launched SomnoDent Herbst Advance Elite, a PDAC-verified milled oral appliance designed to treat mild-to-moderate obstructive sleep apnea.
ProSomnus Sleep Technologies (US)
ProSomnus Sleep Technologies is another major player in the anti-snoring devices market. The company specializes in producing and selling precise intraoral medical devices that provide non-invasive mild-to-moderate obstructive sleep apnea treatment. ProSomnus Sleep Technologies develops its products using a proprietary, highly automated, and scalable manufacturing process. The company ranked as the third-largest in the anti-snoring and sleep apnea devices market, with a growing market share in 2023. ProSomnus has a significant presence in North America and is expanding its reach into other regions, including Europe and Asia. The company offers a diverse portfolio of FDA-cleared and CE-marked oral appliances, designed for personalized and effective treatment of snoring and obstructive sleep apnea (OSA). The company is also dedicated to providing clinical evidence supporting its products' efficacy, positioning it as a trusted name among sleep specialists and healthcare providers.
Related Reports:
Anti-snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, above 60), Distribution Channel (Online, Retail), End User (Homecare, Hospital) - Global Forecast to 2029
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE